Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Major, Solco Healthcare, and Teva – Recall of Valsartan and Valsartan/Hydrochlorothiazide Products
July 16, 2018 - Teva announced a voluntary recall of valsartan and valsartan/hydrochlorothiazide (HCTZ) tablets due to an impurity, N-nitrosodimethylamine (NDMA).
